BROADWOOD CAPITAL INC
Follow13F filer, CIK 1278387, New York, NY
BROADWOOD CAPITAL INC reported $1,702,224,794 across 12 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 100% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-26-001013
- Period
- 2025-12-31
- Reported value
- $1.7B
- Holdings
- 12
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| STAAadded | +1,500,000 | $34.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MNSTreduced | -51,432 | -$3.94M |
| SERreduced | -28,711 | -$54.9K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0000919574-26-001013, largest first. % of portfolio is the value over $1,654,631,939, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| MNSTMONSTER BEVERAGE CORP NEW | 8,198,996 | $629M | 37.99% | -51,432 | Timeline | ||
| AXONAXON ENTERPRISE INC | 693,504 | $394M | 23.8% | 0 | Timeline | ||
| STAASTAAR SURGICAL CO | 15,019,491 | $347M | 20.96% | +1,500,000 | Timeline | ||
| IWMISHARES TR | 474,920 | $117M | 7.07% | 0 | Timeline | ||
| IMDXINSIGHT MOLECULAR DIA INC | 11,410,100 | $85.6M | 5.17% | 0 | Timeline | ||
| LCTXLINEAGE CELL THERAPEUTICS IN | 49,560,992 | $82.8M | 5% | 0 | Timeline | ||
| SERSERINA THERAPEUTICS INC | 54,484 | $104K | 0.01% | -28,711 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Sold out in Q4 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| HANESBRANDS INCHANESBRANDS INC | 1,127,500 | $1.83M | call |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-26-001013 | base | 2026-02-17 | acceptance time not in the bulk data set |